Skip to content

Clinical trials

Esophageal Squamous Cell Carcinoma trials in the Netherlands

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Esophageal Squamous Cell Carcinoma Country / region: Netherlands Clear all

11 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20111
20171
20181
20191
20213
20221
20252

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed5
Recruiting3
Active, not recruiting1
Terminated1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals2
UMC Utrecht2
Daiichi Sankyo1
Exelixis1
Federation Francophone de Cancerologie Digestive1
Merus B.V.1
Sanofi1
Seagen, a wholly owned subsidiary of Pfizer1
Shanghai Chest Hospital1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Esophageal Squamous Cell Carcinoma11
Esophageal Neoplasms3
Squamous Cell Carcinoma of Head and Neck3
Stomach Neoplasms3
Triple Negative Breast Neoplasms3
Carcinoma, Hepatocellular2
Carcinoma, Non-Small-Cell Lung2
Colorectal Neoplasms2
Endometrial Neoplasms2
Melanoma2

Trials

Showing 76 to 11 of 11. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.